ruthenium has been researched along with Kahler Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badillo Patzmay, GV; Kwiecień, A; Lupidi, G; Nabissi, M; Pettinari, C; Pettinari, R; Santoni, G; Smoleński, P; Wołoszyn, A | 1 |
| Devocelle, M; Forster, RJ; Keyes, TE; Moran, N; Neugebauer, U; Pellegrin, Y; Signac, W | 1 |
| Cohen, AS; Shirahama, T | 1 |
3 other study(ies) available for ruthenium and Kahler Disease
| Article | Year |
|---|---|
Ru(ii)-(PTA) and -mPTA complexes with N
Topics: 2,2'-Dipyridyl; Adamantane; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Humans; Multiple Myeloma; Nitrogen; Organophosphorus Compounds; Phenanthrolines; Ruthenium | 2017 |
Ruthenium polypyridyl peptide conjugates: membrane permeable probes for cellular imaging.
Topics: Blood Platelets; Cell Membrane; Cell Membrane Permeability; Cytoplasm; Fluorescent Dyes; Humans; Luminescent Measurements; Molecular Structure; Multiple Myeloma; Oligopeptides; Organometallic Compounds; Oxygen; Pyridines; Ruthenium; Structure-Activity Relationship; Tissue Distribution | 2008 |
Electron microscopic analysis of isolated amyloid fibrils from patients with primary, secondary and myeloma-associated disease. A study utilizing shadowing and negative staining techniques.
Topics: Amyloid; Amyloidosis; Humans; Methods; Microscopy, Electron; Multiple Myeloma; Ruthenium; Staining and Labeling | 1973 |